Cryo Cell International INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
Camac Partners, LLC and affiliated entities have filed an amended Schedule 13D, disclosing beneficial ownership of approximately 6.8% of Cryo-Cell International Inc.'s common stock.
AMEX
Camac Partners and affiliates have disclosed a 5.3% beneficial ownership stake in Cryo-Cell International, Inc., citing undervaluation and plans for strategic engagement.